Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Randomized control trial of prednisolone and doxycycline in patients with acute interstitial nephritis of unknown aetiology

Open access

Abstract

Background: Patients presenting with acute interstitial nephritis (AIN) of unknown aetiology, probably the earliest presentation of chronic kidney disease of unknown aetiology (CKDu), have been treated with oral prednisolone and doxycycline by physicians in Sri Lanka. This trial assessed the effectiveness of prednisolone and doxycycline based on eGFR changes at 6 months in patients with AIN of unknown aetiology. Method: A randomized clinical trial with a 2 × 2 factorial design for patients presenting with AIN of unknown aetiology (n = 59) was enacted to compare treatments with; A-prednisolone, B-doxycycline, C-both treatments together, and D-neither. The primary outcome was a recovery of patients’ presenting renal function to eGFR categories: 61–90 ml/min/1.73m 2 (complete remission– CR) to 31–60 ml/min/1.73m 2 (partial remission– PR) and 0–30 ml/min/1.73m 2 no remission (NR) by 6 months. A secondary outcome was progression-free survival (not reaching < 30 ml/min/1.73m 2 eGFR), by 6–36 months. Analysis was by intention to treat. Results: Seventy patients compatible with a clinical diagnosis of AIN were biopsied for eligibility; 59 AIN of unknown aetiology were enrolled, A = 15, B = 15, C = 14 and D = 15 randomly allocated to each group. Baseline characteristics were similar between groups. The number of patients with CR, PR and NR, respectively, by 6 months, in group A 3:8:2, group B 2:8:3 and group C 8:5:0 was compared with group D 8:6:1. There were no significant differences found between groups A vs. D (p = 0.2), B vs. D (p = 0.1) and C vs. D (p = 0.4). In an exploratory analysis, progression-free survival in prednisolone-treated (A + C) arms was 0/29 (100%) in comparison to 25/30 (83%) in those not so treated (B + D) arms, and the log-rank test was p = 0.02, whereas no such difference found (p = 0.60) between doxycycline-treated (B + C) arms 27/29 (93%) vs those not so treated (A + D) arms 27/30 (90%). Conclusion: Prednisolone and doxycycline were not beneficial for the earliest presentation of CKDu at 6 months. However, there is a potential benefit of prednisolone on the long-term outcome of CKDu. An adequately powered steroid trial using patients reaching < 30 ml/min/1.73m 2 eGFR by 3 years, as an outcome is warranted for AIN of unknown aetiology. Trial registration: Sri Lanka Clinical Trial Registry SLCTR/2014/007, Registered on the 31st of March 2014.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13063-022-07056-4

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Light microscopy images of acute interstitial nephritis (AIN) from CKDu endemic regions of Sri Lanka. Histology of a a focus of tubulitis (TU) stained with haematoxylin and eosin (H&E); magnification × 400. b Sclerosed glomerulus (GS) and atrophic tubule (TA), stained with H&E; magnification × 100
Fig. 1 Light microscopy images of acute interstitial nephritis (AIN) from CKDu endemic regions of Sri Lanka. Histology of a a focus of tubulitis (TU) stained with haematoxylin and eosin (H&E); magnification × 400. b Sclerosed glomerulus (GS) and atrophic tubule (TA), stained with H&E; magnification × 100CC BY · PubMed Central
Fig. 2 Clinical trial profile and patient flowchart
Fig. 2 Clinical trial profile and patient flowchartCC BY · PubMed Central
Fig. 3 Survival plots of prednisolone and doxycycline-treated patients’ vs controls (no prednisolone or no doxycycline)
Fig. 3 Survival plots of prednisolone and doxycycline-treated patients’ vs controls (no prednisolone or no doxycycline)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 7

Metadata

Authors
Badurdeen, Z., Ratnatunga, N., Abeysekera, T., Wazil, A. W. M., Rajakrishna, P. N., Thinnarachchi, J. P., Welagedera, D. D., Ratnayake, N., Alwis, A. P. D., Abeysundara, H., Kumarasiri, R., Taylor, R., & Nanayakkara, N.
Affiliations
  • University of Peradeniya (LK)
  • Teaching Hospital Kandy (LK)
  • UNSW Sydney (AU)
Corresponding author
Badurdeen, Zeid
Venue
Trials
Published
2023-01-05
Volume
24
Issue
1
Pages
11-11
ISSN
1745-6215 (ISSN-L)
OpenAlex
W4313495411
Cited by
6
References
32
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 2
FWCI
1.16
Type
journal article
Language
en
Open access
Licence
Locations
  • Trials (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
University of Peradeniya
Topics
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
  • Health Sciences › Medicine › Nephrology › Nephrotoxicity and Medicinal Plants
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Keywords
acute interstitial nephritis, chronic kidney disease of unknown aetiology, prednisolone, doxycycline, corticosteroid therapy, progression-free survival, treatment effectiveness, Sri Lanka
MeSH terms
Doxycycline, Glucocorticoids, Humans, Nephritis, Interstitial, Prednisolone, Sri Lanka, Renal Insufficiency, Chronic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized control trial of prednisolone and doxycycline in patients with acute interstitial nephritis of unknown aetiology. https://app.cochat.ai/papers/10.1186/s13063-022-07056-4
The paper
Badurdeen, Z., Ratnatunga, N., Abeysekera, T., Wazil, A. W. M., Rajakrishna, P. N., Thinnarachchi, J. P., Welagedera, D. D., Ratnayake, N., Alwis, A. P. D., Abeysundara, H., Kumarasiri, R., Taylor, R., & Nanayakkara, N. (2023). Randomized control trial of prednisolone and doxycycline in patients with acute interstitial nephritis of unknown aetiology. Trials. https://doi.org/10.1186/s13063-022-07056-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.